Two scenarios could change this: First, if performance-enhancement concerns emerged in specific sports (weight-class sports, endurance sports), WADA or sport-specific bodies could add GLP-1 receptor agonists to prohibited lists
2b), corresponding to the gold-bound (AuS) and oxidized sulfur species, respectively
Data from PIONEER 1 were not included because oral semaglutide was given as monotherapy [12], PIONEER 2 was excluded because all patients randomised to oral semaglutide or comparator were receiving background metformin (and no other background glucose-lowering medication) [13], and PIONEER 6 was excluded because it was a cardiovascular outcomes trial [14]
However, evening injections work fine too
ACA exhibited anti-inflammatory, immunomodulatory, antioxidant, anti-obesity, anti-cancer, antiallergic, and anti-asthma effects (Ohnishi et al., 2012
Q Rev Biophys